169 related articles for article (PubMed ID: 38289700)
1. CORR Insights®: Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
Iwata S
Clin Orthop Relat Res; 2024 Mar; 482(3):564-565. PubMed ID: 38289700
[No Abstract] [Full Text] [Related]
2. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
[TBL] [Abstract][Full Text] [Related]
3. Identification of a Novel MAN1A1-ROS1 Fusion Gene Through mRNA-based Screening for Tyrosine Kinase Gene Aberrations in a Patient with Leiomyosarcoma.
Suehara Y; Kohsaka S; Hayashi T; Akaike K; Kurisaki-Arakawa A; Sato S; Kobayashi E; Mizuno S; Ueno T; Morii T; Okuma T; Kurihara T; Hasegawa N; Sano K; Sasa K; Okubo T; Kim Y; Mano H; Saito T
Clin Orthop Relat Res; 2021 Apr; 479(4):838-852. PubMed ID: 33196586
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma.
Zhu G; Benayed R; Ho C; Mullaney K; Sukhadia P; Rios K; Berry R; Rubin BP; Nafa K; Wang L; Klimstra DS; Ladanyi M; Hameed MR
Mod Pathol; 2019 May; 32(5):609-620. PubMed ID: 30459475
[TBL] [Abstract][Full Text] [Related]
5. Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets.
Nacev BA; Sanchez-Vega F; Smith SA; Antonescu CR; Rosenbaum E; Shi H; Tang C; Socci ND; Rana S; Gularte-Mérida R; Zehir A; Gounder MM; Bowler TG; Luthra A; Jadeja B; Okada A; Strong JA; Stoller J; Chan JE; Chi P; D'Angelo SP; Dickson MA; Kelly CM; Keohan ML; Movva S; Thornton K; Meyers PA; Wexler LH; Slotkin EK; Glade Bender JL; Shukla NN; Hensley ML; Healey JH; La Quaglia MP; Alektiar KM; Crago AM; Yoon SS; Untch BR; Chiang S; Agaram NP; Hameed MR; Berger MF; Solit DB; Schultz N; Ladanyi M; Singer S; Tap WD
Nat Commun; 2022 Jun; 13(1):3405. PubMed ID: 35705560
[TBL] [Abstract][Full Text] [Related]
6. Preclinical experimental therapeutic approaches in soft tissue sarcoma.
Hunt KK; Feig BW
Semin Surg Oncol; 1999; 17(1):78-82. PubMed ID: 10402641
[TBL] [Abstract][Full Text] [Related]
7. Molecular targeted therapy for advanced or metastatic soft tissue sarcoma.
Yuan J; Li X; Yu S
Cancer Control; 2021; 28():10732748211038424. PubMed ID: 34844463
[TBL] [Abstract][Full Text] [Related]
8. Soft tissue and bone sarcomas.
Santoro A; Bonadonna G
Cancer Chemother Biol Response Modif; 1991; 12():603-13. PubMed ID: 1931458
[No Abstract] [Full Text] [Related]
9. Expression of growth factor receptors, the focal adhesion kinase, and other tyrosine kinases in human soft tissue tumors.
Weiner TM; Liu ET; Craven RJ; Cance WG
Ann Surg Oncol; 1994 Jan; 1(1):18-27. PubMed ID: 7834423
[TBL] [Abstract][Full Text] [Related]
10. [The necessity and urgency of molecular analysis in the diagnosis and treatment of bone and soft tissue sarcomas].
Niu XH; Xu HR
Zhonghua Yi Xue Za Zhi; 2022 Aug; 102(31):2399-2404. PubMed ID: 36000368
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant therapy for soft tissue sarcomas: does it make a difference?
Scoggins CR
Cancer; 2008 Jun; 112(11):2338-40. PubMed ID: 18338757
[No Abstract] [Full Text] [Related]
12. New biology and therapies in soft tissue sarcomas.
Antman KH
Biomed Pharmacother; 2001 Nov; 55(9-10):553-7. PubMed ID: 11769966
[No Abstract] [Full Text] [Related]
13. [Milestones in the development of orthopedic knowledge and therapy: bone and soft tissue sarcomas].
von Eisenhart-Rothe R; Hardes J
Orthopade; 2021 Oct; 50(10):811-814. PubMed ID: 34529099
[No Abstract] [Full Text] [Related]
14. Emerging predictive biomarkers in the management of bone and soft tissue sarcomas.
Haddox CL; Riedel RF
Expert Rev Anticancer Ther; 2023 May; 23(5):495-502. PubMed ID: 37017995
[TBL] [Abstract][Full Text] [Related]
15. Clinical trials referral resource. Sarcomas.
Cheson BD
Oncology (Williston Park); 1990 Mar; 4(3):42-58. PubMed ID: 2144445
[No Abstract] [Full Text] [Related]
16. Targeted next-generation sequencing of CIC-DUX4 soft tissue sarcomas demonstrates low mutational burden and recurrent chromosome 1p loss.
Lazo de la Vega L; Hovelson DH; Cani AK; Liu CJ; McHugh JB; Lucas DR; Thomas DG; Patel RM; Tomlins SA
Hum Pathol; 2016 Dec; 58():161-170. PubMed ID: 27664537
[TBL] [Abstract][Full Text] [Related]
17. EWSR1-NFATC2 Translocation-associated Sarcoma Clinicopathologic Findings in a Rare Aggressive Primary Bone or Soft Tissue Tumor.
Wang GY; Thomas DG; Davis JL; Ng T; Patel RM; Harms PW; Betz BL; Schuetze SM; McHugh JB; Horvai AE; Cho SJ; Lucas DR
Am J Surg Pathol; 2019 Aug; 43(8):1112-1122. PubMed ID: 30994538
[TBL] [Abstract][Full Text] [Related]
18. Bone and soft tissue sarcomas: summary of the Third United States/Japan Clinical Trials Summit (Seattle, Washington).
Uchida A; Fukushima M; Rothenberg ML; Coltman CA
J Cancer Res Clin Oncol; 1997; 123(11-12):674-7. PubMed ID: 9620228
[No Abstract] [Full Text] [Related]
19. Malignant soft tissue tumors in children.
Thacker MM
Orthop Clin North Am; 2013 Oct; 44(4):657-67. PubMed ID: 24095080
[TBL] [Abstract][Full Text] [Related]
20. The EPH/Ephrin System in Bone and Soft Tissue Sarcomas' Pathogenesis and Therapy: New Advancements and a Literature Review.
Hadjimichael AC; Pergaris A; Kaspiris A; Foukas AF; Kokkali S; Tsourouflis G; Theocharis S
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
